LV5511A3 - Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens - Google Patents
Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiensInfo
- Publication number
- LV5511A3 LV5511A3 LV930621A LV930621A LV5511A3 LV 5511 A3 LV5511 A3 LV 5511A3 LV 930621 A LV930621 A LV 930621A LV 930621 A LV930621 A LV 930621A LV 5511 A3 LV5511 A3 LV 5511A3
- Authority
- LV
- Latvia
- Prior art keywords
- ú3h3⁄4
- tetrazin
- imidazo
- derivative yield
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8125791 | 1981-08-24 | ||
SU823482389A SU1447284A3 (ru) | 1981-08-24 | 1982-08-23 | Способ получени производного @ 3Н @ -имидазо- @ 5,1- @ -1,2,3,5-тетразин-4-она |
Publications (1)
Publication Number | Publication Date |
---|---|
LV5511A3 true LV5511A3 (lv) | 1994-03-10 |
Family
ID=10524141
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LV930621A LV5511A3 (lv) | 1981-08-24 | 1993-06-19 | Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens |
LV931303A LV5621A3 (lv) | 1981-08-24 | 1993-12-03 | [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LV931303A LV5621A3 (lv) | 1981-08-24 | 1993-12-03 | [3H]-imidazo-[5,1-a]-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas metode |
Country Status (29)
Country | Link |
---|---|
JP (1) | JPS5843975A (fr) |
KR (1) | KR890000094B1 (fr) |
AT (1) | AT380256B (fr) |
AU (1) | AU571430B2 (fr) |
BE (1) | BE894175A (fr) |
CA (1) | CA1197247A (fr) |
CH (1) | CH655114A5 (fr) |
DE (2) | DE3231255A1 (fr) |
DK (1) | DK161147C (fr) |
ES (1) | ES8400438A1 (fr) |
FI (1) | FI73434C (fr) |
FR (1) | FR2511679A1 (fr) |
GB (1) | GB2104522B (fr) |
GE (1) | GEP19960641B (fr) |
GR (1) | GR76863B (fr) |
HU (1) | HU186107B (fr) |
IE (1) | IE53408B1 (fr) |
IL (1) | IL66606A (fr) |
IT (1) | IT1152505B (fr) |
LT (1) | LT2436B (fr) |
LU (1) | LU84347A1 (fr) |
LV (2) | LV5511A3 (fr) |
NL (2) | NL192739C (fr) |
NZ (1) | NZ201668A (fr) |
OA (1) | OA07174A (fr) |
SE (1) | SE448543B (fr) |
SU (1) | SU1447284A3 (fr) |
UA (1) | UA5971A1 (fr) |
ZA (1) | ZA826120B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260291A (en) * | 1981-08-24 | 1993-11-09 | Cancer Research Campaign Technology Limited | Tetrazine derivatives |
GB2125402B (en) * | 1982-08-17 | 1985-11-13 | May & Baker Ltd | New tetrazine derivatives |
FR2531958B1 (fr) * | 1982-08-17 | 1986-10-31 | May & Baker Ltd | Nouveaux derive |
US4517182A (en) * | 1983-05-24 | 1985-05-14 | Warner-Lambert Company | 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition |
GB8616125D0 (en) * | 1986-07-02 | 1986-08-06 | May & Baker Ltd | Compositions of matter |
AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
EP2275425A1 (fr) * | 2003-12-30 | 2011-01-19 | Chemagis Ltd. | Nouvelles formes cristallines de temozolomide |
JP5475235B2 (ja) | 2005-01-21 | 2014-04-16 | アステックス・セラピューティクス・リミテッド | 医薬化合物 |
AR060635A1 (es) | 2006-04-27 | 2008-07-02 | Banyu Pharma Co Ltd | Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer |
JP2008081492A (ja) | 2006-08-31 | 2008-04-10 | Banyu Pharmaceut Co Ltd | オーロラa選択的阻害作用を有する新規アミノピリジン誘導体 |
US8916552B2 (en) | 2006-10-12 | 2014-12-23 | Astex Therapeutics Limited | Pharmaceutical combinations |
WO2008044045A1 (fr) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Combinaisons pharmaceutiques |
CA2703489A1 (fr) | 2007-10-23 | 2009-04-30 | Banyu Pharmaceutical Co., Ltd. | Derive de dihydropyrazolopyrimidinone substitue par pyridone |
PE20091101A1 (es) * | 2007-12-18 | 2009-07-26 | Pharminox Ltd | AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO |
EP2367828B1 (fr) * | 2008-11-24 | 2014-06-11 | Reliance Life Sciences Pvt., Ltd. | Procédé de préparation de dérivés de tétrazine |
EP2403339B1 (fr) | 2009-03-06 | 2017-01-18 | Merck Sharp & Dohme Corp. | Thérapie de combinaison anti-cancer avec un inhibiteur de akt et d'autres agents anti-cancer |
WO2010149968A1 (fr) | 2009-06-23 | 2010-12-29 | Pharminox Limited | Composés 3h-imidazo[5,1-d][1,2,3,5-tétrazin-4-one 3-substitués-8-substitués et leur utilisation |
RU2462466C1 (ru) * | 2011-06-24 | 2012-09-27 | Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" | Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ |
US20140271657A1 (en) | 2011-10-12 | 2014-09-18 | Children's Medical Center Corporation | Combinatorial compositions and methods of treating hemoglobinopathies |
IL261721B (en) | 2016-03-15 | 2022-07-01 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for use in the treatment of solid tumors |
KR101847342B1 (ko) * | 2017-05-08 | 2018-04-11 | (주)센텍코리아 | 웨어러블 체지방 연소량 측정기 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2932305A1 (de) * | 1979-08-09 | 1981-02-26 | Basf Ag | Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen |
-
1982
- 1982-08-05 OA OA57766BISD patent/OA07174A/fr unknown
- 1982-08-12 IL IL66606A patent/IL66606A/xx not_active IP Right Cessation
- 1982-08-23 FR FR8214461A patent/FR2511679A1/fr active Granted
- 1982-08-23 DE DE19823231255 patent/DE3231255A1/de active Granted
- 1982-08-23 LU LU84347A patent/LU84347A1/fr unknown
- 1982-08-23 ZA ZA826120A patent/ZA826120B/xx unknown
- 1982-08-23 KR KR8203774A patent/KR890000094B1/ko active
- 1982-08-23 ES ES515176A patent/ES8400438A1/es not_active Expired
- 1982-08-23 NL NL8203286A patent/NL192739C/nl not_active IP Right Cessation
- 1982-08-23 AT AT0319182A patent/AT380256B/de not_active IP Right Cessation
- 1982-08-23 AU AU87493/82A patent/AU571430B2/en not_active Expired
- 1982-08-23 DE DE1999175037 patent/DE19975037I2/de active Active
- 1982-08-23 CA CA000409950A patent/CA1197247A/fr not_active Expired
- 1982-08-23 IT IT22938/82A patent/IT1152505B/it active Protection Beyond IP Right Term
- 1982-08-23 BE BE0/208860A patent/BE894175A/fr not_active IP Right Cessation
- 1982-08-23 GB GB08224155A patent/GB2104522B/en not_active Expired
- 1982-08-23 SU SU823482389A patent/SU1447284A3/ru active
- 1982-08-23 JP JP57144902A patent/JPS5843975A/ja active Granted
- 1982-08-23 DK DK377882A patent/DK161147C/da not_active IP Right Cessation
- 1982-08-23 CH CH5007/82A patent/CH655114A5/fr not_active IP Right Cessation
- 1982-08-23 NZ NZ201668A patent/NZ201668A/en unknown
- 1982-08-23 GR GR69093A patent/GR76863B/el unknown
- 1982-08-23 FI FI822921A patent/FI73434C/fi not_active IP Right Cessation
- 1982-08-23 UA UA3482389A patent/UA5971A1/uk unknown
- 1982-08-23 SE SE8204817A patent/SE448543B/sv not_active IP Right Cessation
- 1982-08-23 IE IE2026/82A patent/IE53408B1/en not_active IP Right Cessation
- 1982-08-23 HU HU822708A patent/HU186107B/hu unknown
-
1993
- 1993-06-19 LV LV930621A patent/LV5511A3/xx unknown
- 1993-09-29 LT LTRP1286A patent/LT2436B/xx not_active IP Right Cessation
- 1993-11-16 GE GEAP19931653A patent/GEP19960641B/en unknown
- 1993-12-03 LV LV931303A patent/LV5621A3/xx unknown
-
1999
- 1999-04-01 NL NL990010C patent/NL990010I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO821886L (no) | Bis-triazolderivat. | |
DK165695C (da) | 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol | |
LV5511A3 (lv) | Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens | |
FI821696A0 (fi) | Hydrodynamiskt smoerjsystem foer kolvanordningar, saerskilt foer stirling-motorer | |
FI822696L (fi) | Sporthjaelm, saerskilt foer ishockey | |
IT8249295A0 (it) | Composti di 1,4-diidropiridina | |
FI813461L (fi) | Arbetsbord, speciellt foer hopsaettningsarbete | |
FI822452A0 (fi) | Stockback, speciellt foer sportgevaer | |
DK267781A (da) | 2,3-bis-hydroxybenzylderivater | |
DE3371781D1 (de) | 1,4-methano-2-benzazepine derivatives | |
FI821091L (fi) | Behaollare foer vaetskor, foeretraedesvis foer drycker | |
GB2107317B (en) | 20,21-dinoreburnamenine derivative | |
FI824279A0 (fi) | 1,4-tiazinkarboxylsyraderivat, deras framstaellning och anvaendning och dessa derivat innehaollande blandningar | |
FI821046A0 (fi) | Foerfarande foer framstaellning av -(3,4,5-trimetoxibenzoyltio)-propionylglycin | |
IT1152515B (it) | 5-fenossifenil-tetraidro-1,3,5-tiadiazin-4-oni | |
DK264082A (da) | 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranon dibenzofuranolderivater | |
DK167182A (da) | 5,6-o-isoalkylidenascorbinsyrederivater | |
KR880001629A (ko) | 1,3,5-트리티안 유도체 | |
DE3173762D1 (de) | Thiazolinotriazine derivatives | |
FI824465L (fi) | Vulkaniserbara, epoxider innehaollande etylenkopolymerer | |
BE890731A (nl) | 2,4-dioxacyclohexanonderivaat | |
IT1189320B (it) | 1-fenil-1,2,3-triazoli impiegabili come disappetenti | |
DE3269141D1 (de) | Benzylazole derivatives | |
TR21560A (tr) | Etilsulfonilmetil-i,3 ogzazolidin herbisid antidot | |
DK154834C (da) | 1,5-diphenylpyrazolin-derivater |